Lung Cancer Trial, Recruiting (NCT07281300)

Lung Cancer Trial, Recruiting NCT07281300 Sponsor: The Hong Kong Polytechnic University Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07281300 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You live in Hong Kong and can understand Cantonese, and are 18 years old or older
You have a confirmed diagnosis of a chest cancer, such as small cell lung cancer, non-small cell lung cancer, or mesothelioma, at any stage of treatment or end-of-life care
You have reported that at least two symptoms are affecting your daily life, and one of those symptoms must be breathlessness
If you have COPD (a lung condition), it is currently stable and not getting worse
You are reasonably active and able to care for yourself, with only limited help needed for daily activities (confirm with trial site)
You are able to have a brain scan called an fMRI
Your doctors expect you to live for more than six months

Who may not be able to join:

You have significant memory or thinking difficulties, severe mental health symptoms, or another medical condition that could make it hard to take part
You are currently taking part in mindfulness, psychological support, or other symptom management programmes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07281300

Sponsor: The Hong Kong Polytechnic University

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT07281300

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You live in Hong Kong and can understand Cantonese, and are 18 years old or older
You have a confirmed diagnosis of a chest cancer, such as small cell lung cancer, non-small cell lung cancer, or mesothelioma, at any stage of treatment or end-of-life care
You have reported that at least two symptoms are affecting your daily life, and one of those symptoms must be breathlessness
If you have COPD (a lung condition), it is currently stable and not getting worse
You are reasonably active and able to care for yourself, with only limited help needed for daily activities (confirm with trial site)
You are able to have a brain scan called an fMRI
Your doctors expect you to live for more than six months

Who may not be able to join:

You have significant memory or thinking difficulties, severe mental health symptoms, or another medical condition that could make it hard to take part
You are currently taking part in mindfulness, psychological support, or other symptom management programmes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Hong Kong Polytechnic University

Registry

ClinicalTrials.gov

Start date

12 August 2025

Est. completion

30 June 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Recruitment rate; Retention rate; Drop-out rate; Adherence rate; Participants' satisfaction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov